Literature DB >> 35156851

Resistance of Streptococcus pneumoniae to Hypothiocyanous Acid Generated by Host Peroxidases.

Heather L Shearer1, Christopher D Kaldor1, Harry Hua1, Anthony J Kettle1, Heather A Parker1, Mark B Hampton1.   

Abstract

Streptococcus pneumoniae is a serious human respiratory pathogen. It generates hydrogen peroxide (H2O2) as part of its normal metabolism, yet it lacks enzymes that remove this oxidant. Here we show that lactoperoxidase and myeloperoxidase, two host enzymes present in the respiratory tract, convert bacterial H2O2 into HOSCN that S. pneumoniae can resist. We found that incubation of S. pneumoniae with myeloperoxidase in chloride-rich buffer killed the bacteria due to formation of toxic hypochlorous acid (HOCl). However, the addition of physiological concentrations of thiocyanate protected the bacteria. Similarly, S. pneumoniae remained viable in the presence of lactoperoxidase and thiocyanate even though the majority of bacterial H2O2 was converted to hypothiocyanous acid (HOSCN). S. pneumoniae and Pseudomonas aeruginosa, another respiratory pathogen, were similarly sensitive to H2O2 and HOCl. In contrast, S. pneumoniae tolerated much higher doses of HOSCN than P. aeruginosa. When associated with neutrophil extracellular traps (NETs), S. pneumoniae continued to generate H2O2, which was converted to HOCl by myeloperoxidase (MPO) present on NETs. However, there was no loss in bacterial viability because HOCl was scavenged by the NET proteins. We conclude that at sites of infection, bacteria will be protected from HOCl by thiocyanate and extracellular proteins including those associated with NETs. Resistance to HOSCN may give S. pneumoniae a survival advantage over other pathogenic bacteria. Understanding the mechanisms by which S. pneumoniae protects itself from HOSCN may reveal novel strategies for limiting the colonization and pathogenicity of this deadly pathogen.

Entities:  

Keywords:  Streptococcus pneumoniae; hydrogen peroxide; hypochlorous acid; hypothiocyanous acid; lactoperoxidase; myeloperoxidase; neutrophil extracellular traps; neutrophils; thiocyanate

Mesh:

Substances:

Year:  2022        PMID: 35156851      PMCID: PMC8929371          DOI: 10.1128/IAI.00530-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  65 in total

1.  Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.

Authors:  Eline Thomson; Siobhain Brennan; Revathy Senthilmohan; Catherine L Gangell; Anna L Chapman; Peter D Sly; Anthony J Kettle; Elizabeth Balding; Luke J Berry; John B Carlin; Rosemary Carzino; Nick de Klerk; Tonia Douglas; Clara Foo; Luke W Garratt; Graham L Hall; Jo Harrison; Anthony Kicic; Ingrid A Laing; Karla M Logie; John Massie; Lauren S Mott; Conor Murray; Faith Parsons; Naveen Pillarisetti; Srinivas R Poreddy; Sarath C Ranganathan; Colin F Robertson; Roy Robins-Browne; Philip J Robinson; Billy Skoric; Stephen M Stick; Erika N Sutanto; Elizabeth Williamson
Journal:  Free Radic Biol Med       Date:  2010-07-18       Impact factor: 7.376

2.  Proportion of community-acquired pneumonia cases attributable to tobacco smoking.

Authors:  J Almirall; C A González; X Balanzó; I Bolíbar
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

3.  Lactoperoxidase and human airway host defense.

Authors:  Corinne Wijkstrom-Frei; Souheil El-Chemaly; Radia Ali-Rachedi; Cynthia Gerson; Miguel A Cobas; Rosanna Forteza; Matthias Salathe; Gregory E Conner
Journal:  Am J Respir Cell Mol Biol       Date:  2003-03-06       Impact factor: 6.914

4.  Assays for the chlorination activity of myeloperoxidase.

Authors:  A J Kettle; C C Winterbourn
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus.

Authors:  Anna L P Chapman; Mark B Hampton; Revathy Senthilmohan; Christine C Winterbourn; Anthony J Kettle
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

6.  Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids.

Authors:  Michael T Ashby; Amy C Carlson; M Jared Scott
Journal:  J Am Chem Soc       Date:  2004-12-15       Impact factor: 15.419

Review 7.  Parental smoking and the risk of middle ear disease in children: a systematic review and meta-analysis.

Authors:  Laura L Jones; Amal Hassanien; Derek G Cook; John Britton; Jo Leonardi-Bee
Journal:  Arch Pediatr Adolesc Med       Date:  2011-09-05

8.  Elemental composition of human airway surface fluid in healthy and diseased airways.

Authors:  L Joris; I Dab; P M Quinton
Journal:  Am Rev Respir Dis       Date:  1993-12

9.  Kinetics and mechanisms of the reaction of hypothiocyanous acid with 5-thio-2-nitrobenzoic acid and reduced glutathione.

Authors:  Péter Nagy; Guy N L Jameson; Christine C Winterbourn
Journal:  Chem Res Toxicol       Date:  2009-11       Impact factor: 3.739

10.  The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases.

Authors:  Yanping Xu; Szilvia Szép; Zhe Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

View more
  1 in total

1.  A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid.

Authors:  Heather L Shearer; Paul E Pace; James C Paton; Mark B Hampton; Nina Dickerhof
Journal:  J Biol Chem       Date:  2022-08-09       Impact factor: 5.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.